A trusted navigation layer for complex healthcare estates, beginning with the NHS.
We are building the governed navigation and arrival platform NHS Trusts need, with a disciplined, evidence-led path to scale.
Investment thesis
Why now, why the NHS
Market
A bottom-up market built from provider and site complexity
We size the opportunity from the number and complexity of NHS acute, community and specialist sites, not top-down industry estimates.
Disclosure: Detailed market sizing, segmentation and dated public evidence are shared in the investor pack following identity and suitability review.
Product & moat
Defensibility beyond a map interface
Governed healthcare location graph
A structured, continuously maintained model of destinations, routes and estate attributes — not a static map export.
Deployment & validation method
A repeatable discovery-to-pilot-to-scale method that de-risks each Trust engagement.
NHS integrations & assurance
Investment in the integration and assurance work that a generic maps product does not do.
Outcome evidence & partner ecosystem
A growing base of pilot evidence and delivery partners that is hard to replicate quickly.
Commercial model
Paid discovery, pilot, subscription and optional services
Expansion runs from a single pathway to a full site, to a Trust, to an Integrated Care System — each stage gated by evidence, not assumption.
Traction
An honest, current picture
Current stage: Hospital WayfinderIQ is in active discovery and pilot conversations with NHS organisations. We separate contracted, live, pilot and pipeline activity clearly in all investor materials, and we do not publish unverified figures.
Responsible scale
Growth that protects patient and NHS trust
Team & advisers
Leadership profiles are shared during the investor conversation
We introduce the team and relevant advisers directly as part of a qualified investor discussion, with any public profile published only with individual consent.
Funding & use of funds
A public summary appropriate to our current round
Specific round details, use-of-funds breakdown and terms are shared through the investor pack after a short suitability review.
Public documents
Approved materials
Confidential and forecast material is never published on this website. Access to controlled documents follows identity and suitability review, and can be revoked or expired at any time.
Request the investor pack
Tell us about your firm, thesis and stage. Requests are reviewed before any confidential material is shared.